NCT03997188View on ClinicalTrials.gov

Zinc-L-Carnosine Prevents Dysphagia in Breast Cancer Patients Undergoing Adjuvant Radiotherapy

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 21, 2015

Primary Completion Date

November 14, 2017

Study Completion Date

December 20, 2017

Conditions
Breast Cancer FemaleDysphagiaAdjuvant Radiotherapy
Interventions
DEVICE

Hepilor

ZLC oral suspension and placebo were both started on Day 1 of RT-HeT and ended when RT was completed or at the onset of dysphagia.

Trial Locations (1)

06132

University of Perugia, Perugia

All Listed Sponsors
lead

Cynthia Aristei

OTHER

NCT03997188 - Zinc-L-Carnosine Prevents Dysphagia in Breast Cancer Patients Undergoing Adjuvant Radiotherapy | Biotech Hunter | Biotech Hunter